Global Lipid Nanoparticles Market 2023

March 2023 | 37 pages | ID: G64B02AAFF76EN
Gen Consulting Company

Abstracts

According to the latest estimates, the global lipid nanoparticles market is set to achieve an incremental growth of USD 295.7 million, accelerating at a CAGR of almost 7.4% during the forecast period 2023-2029.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, application, and region. The global market data on lipid nanoparticles can be segmented by product: mRNA-lipid nanoparticles, siRNA-lipid nanoparticles, others. The mRNA-lipid nanoparticles segment held the largest revenue share in 2022. Lipid nanoparticles market is further segmented by application: scientific research, vaccines and drugs. Among these, the vaccines and drugs segment was accounted for the highest revenue generator in 2022. Based on region, the lipid nanoparticles market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America captured the largest share of the market in 2022.

The global lipid nanoparticles market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Avanti Polar Lipids Inc., Evonik Industries AG, Exelead Inc., Genevant Sciences GmbH, Lipoid GmbH, Merck KGaA, Nippon Fine Chemical Co. Ltd., Precision NanoSystems Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Lipid Nanoparticles Market
• Identify segments/areas to invest in over the forecast period in the Global Lipid Nanoparticles Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. SUMMARY

PART 2. INTRODUCTION

Study period
Geographical scope
Market segmentation

PART 3. LIPID NANOPARTICLES MARKET OVERVIEW

PART 4. MARKET BREAKDOWN BY PRODUCT

MRNA-lipid nanoparticles
SiRNA-lipid nanoparticles
Others

PART 5. MARKET BREAKDOWN BY APPLICATION

Scientific research
Vaccines and drugs

PART 6. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 7. KEY COMPANIES

Avanti Polar Lipids Inc.
Evonik Industries AG
Exelead, Inc.
Genevant Sciences GmbH
Lipoid GmbH
Merck KGaA
Nippon Fine Chemical Co., Ltd.
Precision NanoSystems Inc.

PART 8. METHODOLOGY